Surely, if I am a hospital operator in the region, and I mean Middle East as well as Asian, the MERS outbreak puts all risk committees at these hospitals on alert for prevention and that must bring Genetic Signatures into the frame.
Isn't this what there business is all about? Early detection and therefore prevention of such an outbreak.
R
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.015(5.88%) |
Mkt cap ! $61.32M | |||
| Open | High | Low | Value | Volume |
| 27.0¢ | 27.0¢ | 27.0¢ | $1.269K | 4.699K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15674 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 20000 | 1 |
View Market Depth
| Last trade - 14.04pm 19/09/2025 (20 minute delay) ? |
| GSS (ASX) Chart |